Holmusk is solving some of the most complex challenges in neuropsychiatry, using AI/ML techniques and our proprietary real-world data. Below is a selection of our conference presentations and peer-reviewed publications.
Category
Type

American Society of Clinical Psychopharmacology
Impact of Negative Symptoms on Healthcare Resource Utilization and Costs in Schizophrenia: A Real-World Data Analysis
View

American Psychiatric Association
Reliably identifying clinically relevant neuropsychiatric symptoms in patients with dementia using mental status examination data
View

Academy of Managed Care Pharmacy
Healthcare resource utilization among patients with schizophrenia and negative symptoms: a real-world data study
View

Journal of Neurology, Neurosurgery, and Psychiatry
Psychiatric comorbidities cluster early after onset in MOGAD: a cross-sectional comparative study with MS and NMOSD
View

SCHIZOPHRENIA INTERNATIONAL RESEARCH SOCIETY
Associations Between Negative Symptoms in Schizophrenia, Psychotherapy Exposure, and Healthcare Resource Utilisation and Clinical Outcomes: A Non-Interventional Observational Study
View

Schizophrenia International Research Society
The Weight of Mental Illness in the US: Obesity Burden and GLP-1 Receptor Agonist Treatment Inequalities in Mental Health Care
View

Schizophrenia International Research Society
Monitoring for abnormal movements associated with tardive dyskinesia in routine care: a retrospective analysis of electronic health records
View

Schizophrenia International Research Society
Natural language processing assisted chart review of patients with suspected or diagnosed clozapine induced myocarditis (CIM)
View
.png)
BMC Psychiatry
Treatment trajectories of patients with borderline personality disorder prescribed pharmacotherapy: real-world insights from a retrospective observational study
View

Psych Congress
Healthcare resource utilization among patients with schizophrenia and negative symptoms: A real-world data study
View

Neuropsychiatric Disease and Treatment
Sertraline for the Treatment of Major Depressive Disorder in the US: Effectiveness and Acceptability in Real-World Practice
View

DGPPN GERMAN ASSOCIATION FOR PSYCHIATRY, PSYCHOTHERAPY AND PSYCHOSOMATICS
Real-world Insights Into the Demographic, Treatment, and Clinical Characteristics of Patients with Schizophrenia in Germany: A Retrospective Claims Analysis Using the InGef Database
View

BMJ Open
Examining differences in clinical and demographic characteristics of patients with post-traumatic stress disorder across adult treatment subgroups based on the NeuroBlu database: a non-interventional, retrospective cohort study
View

Neuroscience Education Institute
Healthcare resource utilization among patients with schizophrenia and negative symptoms: a real-world data study
View

European College of Neuropsychopharmacology
Assessment of anxiety severity among patients with generalized anxiety disorder prescribed venlafaxine: A retrospective, observational, real-world study
View

European College of Neuropsychopharmacology
Monitoring for abnormal movements associated with tardive dyskinesia in routine care: a retrospective analysis of electronic health records
View

European College of Neuropsychopharmacology
Semaglutide and cognitive function in individuals with mental disorders
View

Journal of the American Medical Informatics Association
Predicting treatment retention in medication for opioid use disorder: a machine learning approach using NLP and LLM-derived clinical features
View

Psych Congress
Assessment of anxiety severity among patients with generalized anxiety disorder on venlafaxine: A retrospective, observational, real-world study
View

Journal of Affective Disorders
Demographic and clinical characteristics of patients with borderline personality disorder: Real-world insights from a retrospective observational study
View

BMJ Mental Health
Transdiagnostic early warning score for psychiatric hospitalisation: development and evaluation of a prediction model
View

British Association for Psychopharmacology
Symptom Instability as an Early Warning Sign of Transition to Severe Depression
View

American Psychiatric Association
Instability of Depressive Symptoms Predicts the Onset of Severe Depression Among Patients with Mild-to-Moderate Illness
View

American Psychiatric Association
Temporal and Contextual Detection of Five Depressive Disorder Symptoms from Unstructured Electronic Health Record Notes Using a Trained Natural Language Processing Model
View

BIOLOGICAL PSYCHIATRY JOURNAL
Revealing the Role of Medications in the Elevated Risk of Cardiovascular Disorders in Women With Bipolar Disorder Using Machine Learning.
View

BMC Psychiatry
Identifying the diagnostic gap of tardive dyskinesia: An analysis of semi-structured electronic health record data
View

Schizophrenia International Research Society
Identifying patients with tardive dyskinesia using the Schooler-Kane criteria and diagnostic codes in real-world data
View

Schizophrenia International Research Society
Association between negative symptoms in schizophrenia and outcomes of weight gain and level of functioning: a real-world data study in the United States
View

Schizophrenia International Research Society
A non-interventional observational study to describe demographic and clinical features of patients with negative symptoms in schizophrenia
View

Schizophrenia International Research Society
Comparing the prevalence of schizophrenia symptoms using the mental state examination and validated rating instruments
View

BMJ Open
Retrospective cohort study of long-acting injectable (LAI) antipsychotic initiation in the inpatient setting: impact of LAI characteristics on transition and continuation of care among patients with schizophrenia in the USA
View
.png)
BMC Medical Informatics and Decision Making
Natural language processing to identify suicidal ideation and anhedonia in major depressive disorder
View

American college of neuropsychopharmacology
Prediction of Optimal Treatment Selection Between ECT and Ketamine to Treat Suicidal Ideation
View

Psych Congress
Negative symptoms and cognitive impairment in US patients with schizophrenia: A real-world descriptive study using the NeuroBlu database
View

European College of Neuropsychopharmacology
Enhancing mental healthcare through artificial intelligence: A study of depressive disorder symptoms extraction from clinical notes with natural language processing
View

European College of Neuropsychopharmacology
Can the evidence for sertraline in clinical trials be demonstrated in real-world clinical practice? A retrospective, observational, real-world study
View

European College of Neuropsychopharmacology
Identifying patients with stable schizophrenia using electronic health records
View

BMC Psychiatry
Real world analysis of treatment change and response in adults with attention-deficit/hyperactivity disorder (ADHD) alone and with concomitant psychiatric comorbidities: results from an electronic health record database study in the United States
View

Journal of Affective Disorders
Healthcare resource utilisation and suicidal ideation amongst adolescents in the US with posttraumatic stress disorder, major depressive disorder, and substance use disorders using electronic health records
View

Borderline Personality Disorder and Emotoipn Dysregulation
Characterizing psychopharmacological prescribing practices in a large cohort of adolescents with borderline personality disorder
View

BMJ Open
A real-world data analysis of electronic health records to investigate the associations of predominant negative symptoms with healthcare resource utilisation, costs and treatment patterns among patients with schizophrenia
View

The Journal of Clinical Psychiatry
Learning by Doing: Can Our Collective Experiences as Clinicians Improve Mental Health Care?
View

Addiction
Predictability of buprenorphine-naloxone treatment retention: A multi-site analysis combining electronic health records and machine learning
View

American Society of Clinical Psychopharmacology
The clinical global impression of severity (CGI-S): Bridging the research-practice gap
View

Anxiety and Depression Association of America
Real-world insights into the heterogeneity of treatment patterns and clinical outcomes in patients with post-traumatic stress disorder (PTSD)
View

Schizophrenia International Research Society
Clinical characteristics of patients with cognitive impairment associated with schizophrenia
View

Schizophrenia International Research Society
Long-term patient functioning and illness burden associated with cognitive impairment and negative symptoms in schizophrenia
View

Neuropsychiatric Disease and Treatment
Psychometric evaluation and linking of the PHQ-9, QIDS-C, and VQIDS-C in a real-world population with major depressive disorder
View

Natural Language Processing Journal
Enhancing pre-trained contextual embeddings with triplet loss as an effective fine-tuning method for extracting clinical features from electronic health record derived mental health clinical notes
View

ISPOR EU
Comparing factors associated with first and recurrent psychiatric hospitalizations in adult patients with major depressive disorder using Cox proportional hazard model and extensions
View

European College of Neuropsychopharmacology Congress
Examining differences in clinical and demographic characteristics of patients with post-traumatic stress disorder across adults and paediatric subgroups
View

European College of Neuropsychopharmacology Congress
Treatment trajectory in people with major depressive disorder from diagnosis to 12 months post-diagnosis
View

European College of Neuropsychopharmacology Congress
Treatment trajectory in people with borderline personality disorder from diagnosis to 12 months post-diagnosis
View

European College of Neuropsychopharmacology Congress
Clinical characteristics of people with borderline personality disorder at 12 months prior to first diagnosis and at diagnosis
View

European College of Neuropsychopharmacology
Examining real-world evidence of clinical outcomes, healthcare resource utilisation, and treatment patterns of patients with post-traumatic stress disorder
View

Therapeutic Advances in Psychopharmacology
Comparative effectiveness study of paliperidone palmitate 6-month with a real-world external comparator arm of paliperidone palmitate 1-month or 3-month in patients with schizophrenia
View

Schizophrenia Research
Associations of comorbid substance use disorders with clinical outcomes in schizophrenia using electronic health record data
View

International Conference on Pharmacoepidemiology
Real-world evidence on the burden of known side-effects of typical and atypical antipsychotic medications in patients with schizophrenia
View

Hispanic Health Care International
Poverty and Suicidal Ideation Among Hispanic Mental Health Care Patients Leading up to the COVID-19 Pandemic
View

American Society of Clinical Psychopharmacology
Elevated anxiety in patients with major depressive disorder
View

Schizophrenia International Research Society
Identifying the treatment gap of undiagnosed tardive dyskinesia: an analysis of unstructured electronic health record data
View

International Professional Society for Health Economics and Outcomes Research
Investigating trends of behavioral healthcare resource utilization burden in children and adolescents with suicidal symptoms in the United States: An analysis of electronic health record data
View

International Professional Society for Health Economics and Outcomes Research
Development of a novel transdiagnostic predictor of psychiatric hospitalization using early trajectories of the Clinical Global Impression Scale
View

International Professional Society for Health Economics and Outcomes Research
A comparison of oral aripiprazole with an ingestible sensor to oral atypical antipsychotic treatment in a real-world setting for the risk of hospitalization in adults with schizophrenia
View

European Congress of Psychiatry
A real-world data analysis of Clinical Global Impression-Severity (CGI-S) as a transdiagnostic predictor of psychiatric hospitalization
View
Academy of Managed Care Pharmacy
Real-world insights into long-acting injectable antipsychotic agent initiation in the inpatient setting and transition/continuation of care: Impact of LAI characteristics on outcomes among patients with schizophrenia
View

The Lancet Psychiatry
Early trajectory of clinical global impression as a transdiagnostic predictor of psychiatric hospitalisation: a retrospective cohort study
View
Academy of Managed Care Pharmacy
Early clinical instability and increased risk of psychiatric hospitalization: real-world evidence from an analysis of electronic health record data
View

ClinicoEconomics and Outcomes Research
Life engagement improvement following initiation of brexpiprazole treatment in patients with MDD: A naturalistic, retrospective real-world study
View

Current Medical Research and Opinion
Psychiatric Healthcare Resource Utilization Following Initiation of Aripiprazole Once-Monthly: A Retrospective Real-world Study
View

American College of Neuropsychopharmacology
Gender Differences in Adult ADHD Symptoms: Network Analysis of Real-world Data
View

National Institute of Health Research MindTech
The impact of a caseload management tool (MaST) on community mental healthcare service delivery
View

DGPPN German Association for Psychiatry, Psychotherapy and Psychosomatics
The impact of COVID-19 on psychiatric illness severity and care delivery: A real-world data study
View

DGPPN German Association for Psychiatry, Psychotherapy and Psychosomatics
The application of natural language processing to real-world electronic health record data to identify positive and negative symptoms in schizophrenia
View

International Professional Society for Health Economics and Outcomes Research: Europe
Transdiagnostic Analysis of Mental Disorder Symptoms Associated with Increased Frequency of Psychiatric Hospitalization
View

International Professional Society for Health Economics and Outcomes Research: Europe
Predictors Of Hospitalization In Patients With Newly Diagnosed Major Depressive Disorder: A Real-world Evidence Study
View

National Association of Health Data Organizations
Natural language processing and machine learning models to accelerate generation and application of real-world evidence in behavioral health
View

American Academy of Child & Adolescent Psychiatry
The Impact of Executive Functioning Deficit on Illness Severity in Patients with an ADHD Diagnosis: a Real-world Data Study
View

European College of Neuropsychopharmacology
Antipsychotic prescribing trends in schizophrenia between 2011 and 2021: real-world data from a US electronic health record database
View

European College of Neuropsychopharmacology
The Association of Comorbid Substance Use Disorders with Time to Treatment Discontinuation in Patients with Schizophrenia
View